{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:41:15Z","timestamp":1791942075042,"version":"4.3.4"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi251208-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Primary hyperparathyroidism (pHPT) is a common endocrine disorder linked to elevated parathyroid hormone and calcium levels, which may contribute to increased cardiometabolic risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251208-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the long-term cardiometabolic risks associated with pHPT and to assess whether parathyroidectomy is associated with reduced incidence of these outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251208-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cohort study used data from Clalit Health Services, Israel\u2019s largest health care organization.  A total of 50\u202f199 patients diagnosed with pHPT between January 1, 2000, and November 29, 2023, and 150\u202f265 matched controls (matched 1:3 by age, sex, and socioeconomic status) were included. Patients with secondary hyperparathyroidism were excluded. Among patients with pHPT, 6654 underwent parathyroidectomy. Duration of follow-up was as long as 15 years. Data were analyzed from November 1, 2024, to April 1, 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251208-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Diagnosis of pHPT and parathyroidectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251208-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Incidence of hypertension, type 2 diabetes (T2D), cardiovascular disease (CVD), and cerebrovascular accidents (CVA). Events were analyzed using Kaplan-Meier curves and multivariable-stratified Cox proportional hazards regression models adjusted for Charlson Comorbidity Index, body mass index, and ethnicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251208-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 200\u202f464 individuals were included (median age, 66 [IQR, 55-75] years; 136 884 [68.3%] female), comprising 50\u202f199 patients with pHPT and 150\u202f265 matched control individuals. Patients with pHPT exhibited an elevated long-term risk of hypertension (adjusted hazard ratio [AHR], 1.22; 95% CI, 1.17-1.33;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), T2D (AHR, 1.07; 95% CI, 1.01-1.16;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.02), CVD (AHR, 1.28; 95% CI, 1.21-1.42;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), and CVA (AHR, 1.22; 95% CI, 1.17-1.33;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) compared with controls. Between patients who underwent parathyroidectomy and those who underwent nonsurgical management, parathyroidectomy was associated with a reduced risk of T2D only, with the incidence decreasing from 15.18 (95% CI, 14.58-15.81) to 10.77 (95% CI, 9.80-11.83) per 1000 person-years (AHR, 0.56; 95% CI, 0.30-0.89;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251208-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The findings of this cohort study suggest that pHPT is associated with increased long-term cardiometabolic risks. Parathyroidectomy may be associated with reduced incidence of T2D, supporting consideration of surgical intervention in appropriate patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.44623","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:30:36Z","timestamp":1763742636000},"page":"e2544623","source":"Crossref","is-referenced-by-count":4,"title":["Parathyroidectomy and Cardiometabolic Risks in Patients With Primary Hyperparathyroidism"],"prefix":"10.1001","volume":"8","author":[{"given":"Nir","family":"Tsur","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Rabin Medical Center\u2013Beilinson Hospital, Petach Tikva, Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nofar","family":"Edri","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Rabin Medical Center\u2013Beilinson Hospital, Petach Tikva, Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomer","family":"Kerman","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Rabin Medical Center\u2013Beilinson Hospital, Petach Tikva, Israel"},{"name":"Joyce & Irving Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be\u2019er-Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeela","family":"Talmor-Barkan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Department of Cardiology, Rabin Medical Center, Petah Tiqva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shir","family":"Kushnir","sequence":"additional","affiliation":[{"name":"Research Authority, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Bachar","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Rabin Medical Center\u2013Beilinson Hospital, Petach Tikva, Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"1","key":"zoi251208r1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12872-019-1093-4","article-title":"Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.","volume":"19","author":"Beysel","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"zoi251208r2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ando.2015.03.001","article-title":"Asymptomatic and mild primary hyperparathyroidism.","volume":"76","author":"Macfarlane","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6","key":"zoi251208r3","doi-asserted-by":"publisher","first-page":"R297","DOI":"10.1530\/EJE-17-0485","article-title":"Cardiovascular manifestations of primary hyperparathyroidism: a narrative review.","volume":"177","author":"Pepe","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"zoi251208r4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/0115701611280905231227045826","article-title":"Hyperparathyroidism and peripheral arterial disease.","volume":"22","author":"Antignani","year":"2024","journal-title":"Curr Vasc Pharmacol"},{"issue":"21","key":"zoi251208r5","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.3390\/jcm12216718","article-title":"Primary hyperparathyroidism and cardiovascular disease: an association study using clinical natural language processing systems and big data analytics.","volume":"12","author":"Iglesias","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"zoi251208r6","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1210\/clinem\/dgab157","article-title":"Meta-analysis on the effect of mild primary hyperparathyroidism and parathyroidectomy upon arterial stiffness.","volume":"106","author":"Bernardi","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"zoi251208r7","first-page":"1065","article-title":"Parathyroid diseases and metabolic syndrome.","volume":"46","author":"Modica","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"zoi251208r8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40618-021-01645-x","article-title":"Cardiac structural and functional abnormalities in primary hyperparathyroidism.","volume":"45","author":"Purra","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"zoi251208r9","doi-asserted-by":"publisher","first-page":"E638","DOI":"10.1210\/jc.2012-4007","article-title":"Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study.","volume":"98","author":"van Ballegooijen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"zoi251208r10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2020.0538","article-title":"Diagnosis and management of primary hyperparathyroidism.","volume":"323","author":"Zhu","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"zoi251208r11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management: a Canadian and international consensus.","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"issue":"7","key":"zoi251208r12","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/cncr.29123","article-title":"Should small papillary thyroid cancer be observed? a population-based study.","volume":"121","author":"Nilubol","year":"2015","journal-title":"Cancer"},{"issue":"43","key":"zoi251208r13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007255","article-title":"Echocardiogram changes following parathyroidectomy for primary hyperparathyroidism: a systematic review and meta-analysis.","volume":"96","author":"Best","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"zoi251208r14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.7326\/M21-4416","article-title":"Mortality and morbidity in mild primary hyperparathyroidism: results from a 10-year prospective randomized controlled trial of parathyroidectomy versus observation.","volume":"175","author":"Pretorius","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi251208r15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12020-020-02519-7","article-title":"The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis.","volume":"72","author":"Yavari","year":"2021","journal-title":"Endocrine"},{"issue":"6","key":"zoi251208r16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/jamasurg.2019.6358","article-title":"Parathyroidectomy and hypertension.","volume":"155","author":"Hussain","year":"2020","journal-title":"JAMA Surg"},{"issue":"6","key":"zoi251208r17","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.surg.2013.06.047","article-title":"Cardiovascular dysfunction in symptomatic primary hyperparathyroidism and its reversal after curative parathyroidectomy: results of a prospective case control study.","volume":"154","author":"Agarwal","year":"2013","journal-title":"Surgery"},{"issue":"5","key":"zoi251208r18","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/jcm11051373","article-title":"Effect of parathyroidectomy on metabolic homeostasis in primary hyperparathyroidism.","volume":"11","author":"Frey","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"zoi251208r19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.numecd.2020.12.029","article-title":"Impact of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism: a narrative review.","volume":"31","author":"Frey","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"zoi251208r20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1530\/EJE-10-0201","article-title":"Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy.","volume":"163","author":"Farahnak","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"20","key":"zoi251208r21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"zoi251208r22","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/SLA.0000000000005999","article-title":"Parathyroidectomy and the risk of major cerebrovascular and cardiovascular events in the elderly.","volume":"278","author":"Grant","year":"2023","journal-title":"Ann Surg"},{"issue":"6","key":"zoi251208r23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1464-5491.2011.03516.x","article-title":"Adult-onset diabetes among Arabs and Jews in Israel: a population-based study.","volume":"29","author":"Kalter-Leibovici","year":"2012","journal-title":"Diabet Med"},{"issue":"6","key":"zoi251208r25","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3390\/jcm11061577","article-title":"Continuous decline in myocardial infarction and heart failure hospitalizations during the first 12 months of the COVID-19 pandemic in Israel.","volume":"11","author":"Lavie","year":"2022","journal-title":"J Clin Med"},{"key":"zoi251208r26","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2025.3081","article-title":"Parathyroidectomy and risk of incident diabetes in patients with primary hyperparathyroidism.","author":"Liu","year":"2025","journal-title":"JAMA Surg"},{"issue":"4","key":"zoi251208r27","first-page":"333","article-title":"Arterial hypertension and primary hyperparathyroidism\u2013a reversible condition?","volume":"115","author":"Hamel","year":"1995","journal-title":"Rev Med Suisse Romande"},{"issue":"1","key":"zoi251208r28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3109\/08037059309077520","article-title":"Hypertension, primary hyperparathyroidism and the parathyroid hypertensive factor.","volume":"2","author":"Lind","year":"1993","journal-title":"Blood Press"},{"key":"zoi251208r24","unstructured":"Data-sharing platform. MDClone. Accessed April 1, 2024. https:\/\/mdclone.com\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2841746\/tsur_2025_oi_251208_1763141592.66254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:30:37Z","timestamp":1763742637000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2841746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.44623","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}